Skip to main content
Clinical Trials/KCT0002576
KCT0002576Recruiting未知

Efficacy and safety of Lycium Chinese extract complex on women with osteopenia; A 40week, Randomized, Double-blind, Placebo-Controlled Clinical Trial

Dongwoodang0 sites100 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
45(Year) to 75(Year) (—)
Sex
Female

Inclusion Criteria

  • 1) female subjects at least more than 45years of age inclusive with menopause
  • a. have no orrhea for 12months
  • b. have last orrhea since 6months ago and FSH > 40mlU/mL
  • c. have both ovariectomy since 6weeks
  • d. have hysterectomy and FSH > 40mlU/mL
  • 2) have Osteopenia by DXA(Dual energy X-ray absorptiometry)
  • 3) BMI of 18.5-35.0kg/m2
  • 4) Subjects who agree the particpation in the trial and submit informed and consent before the beginning of the trial.

Exclusion Criteria

  • 1)The Patients with severe vitamin D which have more than 200IU per day or Calcium before 2weeks from visit2
  • 2)The Patients with severe Bisphosphonate
  • 3)AST(aspartate transaminase), ALT(alanine transaminase) = 2 times the upper limit of normal.
  • 4)eGFR(Estimated glomerular filtration rate) value =60 mL/min/1.73 m2
  • 5)The Patients who had atraumatic fracture or have lumbarcompression fracture
  • 6)Subjects which in the opinion investigator could affect preclude evluation of response

Investigators

Sponsor
Dongwoodang

Similar Trials